References
- Mac Donald D I. Cocaine leads emergency department drug visits. JAMA 1987; 258: 2029
- Gay G R. Clinical management of acute and chronic cocaine poisoning. Ann Emerg Med 1982; 11: 562–572
- Om A, Ellahham S, Ornato J P, et al. Medical complications of cocaine: Possible relationship to low plasma cholinesterase enzyme. Am Heart J 1993; 125: 1114–1117
- Stewart D J, Inaba T, Lucassen M, Kalow W. Cocaine metabolism: Cocaine and norcocaine hydrolysis by liver and serum esterases. Clin Pharmacol Ther 1979; 25: 464–468
- Stewart D J, Inaba T, Tang B K, Kalow W. Hydrolysis of cocaine in human plasma by cholinesterase. Life Sci 1977; 20: 1557–1563
- Inaba T, Stewart D J, Kalow W. Metabolism of cocaine in man. Clin Pharmacol Ther 1978; 23: 547–552
- Leighty E G, Fentiman A F, Jr. Metabolism of cocaine to norcocaine and benzoyl ecgonine by an in vitro microsomal enzyme system. Res Commun Chem Pathol Pharmacol 1974; 8: 65–74
- Stewart D J, Inaba T, Kalow W. N-demethylation of cocaine in the rat and in isolated rat hepatocytes: Comparison with aminopyrine demethylation. J Pharmacol Exp Ther 1978; 207: 171–177
- Dean R A, Christian C D, Sample R H, Bosron W F. Human liver cocaine esterases: Ethanol-mediated formation of ethylcocaine. FASEB J 1991; 5: 2735–2739
- Ambre J J, Fischman M, Ruo T I. Urinary excretion of ecgonine methyl ester, a major metabolite of cocaine in humans. J Anal Toxicol 1984; 8: 23–25
- Jatlow P, Barash P G, Van Dyke C, Radding J, Byck R. Cocaine and succinylcholine sensitivity: A new caution. Anesth Analg 1979; 58: 235–238
- Hoffman R S, Henry G C, Howland M A, Weisman R S, Weil L, Goldfrank L R. Association between life-threatening cocaine toxicity and plasma cholinesterase activity. Ann Emerg Med 1992; 21: 247–253
- Devenyi P. Cocaine complications and pseudocholin-esterase. Ann Intern Med 1989; 110: 167–168
- Hoffman R S, Henry G C, Wax P M, Weisman R S, Howland M A, Goldfrank L R. Decreased plasma cholinesterase activity enhances cocaine toxicity in mice. J. Pharmacol Exp Ther 1992; 263: 698–702
- Hoffman R S, Morasco R, Goldfrank L R. Administration of purified human plasma cholinesterase protects against cocaine toxicity in mice. J Toxicol Clin Toxicol 1996; 34: 259–266
- Hatsukami D K, Keenan R, Carroll M, Colon E, Geiske D, Wilson B, Huber M. A method for delivery of precise doses of smoked cocaine-base to humans. Pharmacol Biochem Behav 1990; 36: 1–7
- Kalow W, Lindsay H A. A comparison of optical and manometric methods for the assay of human serum cholinesterase. Can J Biochem Physiol 1955; 33: 568–574
- Lange R A, Cigarroa R G, Flores E D, et al. Potentiation of cocaine-induced coronary vasoconstriction by beta-adrenergic blockade. Ann Intern Med 1990; 112: 897–903
- Schwartz H J, Johnson D. In vitro competitive inhibition of plasma cholinesterase by cocaine: Normal and variant genotypes. J Toxicol Clin Toxicol 1996; 34: 77–81
- Herschman Z, Aaron C. Prolongation of cocaine effect. Anesthesiology 1991; 74: 631–632